Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

The biotech firm said Tuesday that the shot showed a better immune response to both original COVID and the Omicron variations than did its current Spikevax vaccine. Moderna wants to combine the ...

In the trial, mRNA-1283 elicited a higher immune response against the SARS-CoV-2 virus, including the Omicron BA ... mRNA-1283 in the near future. Moderna CEO Stéphane Bancel said: “We are ...

Last week, the European Commission expanded its order for Moderna's Omicron-targeted vaccine by ... the disease and save lives," said MHRA CEO Dr June Raine. "What this bivalent vaccine gives ...

Moderna CEO Stephane Bancel ... These vaccines are designed to help protect against the Omicron subvariant BA.1 and an early strain of the novel coronavirus. Moderna’s new plant would help ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences and the appointment of vaccine skeptic Robert F. Kennedy Jr. as U.S ...

Update (September 2): The CDC greenlighted the use of the Moderna and Pfizer Omicron boosters yesterday, meaning that the shots could start being administered within days. People must have had their ...

Moderna's updated Spikevax shot includes 25 µg of spike protein mRNA from BA.4/BA.5 and 25 µg from the original strain of SARS-CoV-2, and has been authorised for the over-18s. It has also been ...